Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

BUY
$256.56 - $292.34 $115,452 - $131,553
450 Added 8.33%
5,850 $1.63 Million
Q4 2022

Feb 13, 2023

SELL
$252.44 - $306.72 $416,526 - $506,088
-1,650 Reduced 23.4%
5,400 $1.5 Million
Q3 2022

Nov 04, 2022

SELL
$194.69 - $268.46 $350,442 - $483,227
-1,800 Reduced 20.34%
7,050 $1.88 Million
Q2 2022

Aug 03, 2022

BUY
$187.54 - $223.02 $225,048 - $267,624
1,200 Added 15.69%
8,850 $1.81 Million
Q1 2022

May 03, 2022

BUY
$193.77 - $244.14 $474,736 - $598,143
2,450 Added 47.12%
7,650 $1.61 Million
Q4 2021

Feb 09, 2022

BUY
$223.92 - $287.77 $167,940 - $215,827
750 Added 16.85%
5,200 $1.25 Million
Q3 2021

Nov 12, 2021

BUY
$282.99 - $369.05 $721,624 - $941,077
2,550 Added 134.21%
4,450 $1.26 Million
Q2 2021

Aug 11, 2021

SELL
$259.0 - $414.71 $1.89 Million - $3.03 Million
-7,300 Reduced 79.35%
1,900 $658,000
Q1 2021

May 21, 2021

SELL
$242.95 - $284.63 $623 Million - $730 Million
-2,564,500 Reduced 99.64%
9,200 $2.57 Million
Q1 2021

May 17, 2021

BUY
$242.95 - $284.63 $623 Million - $730 Million
2,563,000 Added 23953.27%
2,573,700 $9.2 Million
Q4 2020

Feb 16, 2021

SELL
$236.26 - $355.63 $200,821 - $302,285
-850 Reduced 7.36%
10,700 $2.62 Billion
Q2 2020

Aug 13, 2020

BUY
$258.66 - $342.55 $232,794 - $308,295
900 Added 8.45%
11,550 $3.09 Billion
Q1 2020

May 15, 2020

SELL
$268.85 - $341.04 $241,965 - $306,936
-900 Reduced 7.79%
10,650 $3.37 Billion
Q4 2019

Feb 11, 2020

SELL
$220.06 - $304.07 $682,186 - $942,617
-3,100 Reduced 21.16%
11,550 $3.43 Billion
Q3 2019

Nov 12, 2019

BUY
$217.44 - $243.88 $304,416 - $341,432
1,400 Added 10.57%
14,650 $3.41 Billion
Q2 2019

Aug 15, 2019

BUY
$219.29 - $241.72 $1.1 Million - $1.21 Million
5,000 Added 60.61%
13,250 $3.1 Billion
Q1 2019

May 10, 2019

BUY
$216.71 - $338.96 $1.79 Million - $2.8 Million
8,250 New
8,250 $1.95 Billion

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Factorial Partners, LLC Portfolio

Follow Factorial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Factorial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Factorial Partners, LLC with notifications on news.